Sotera Health Company, a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced that Chairman and CEO Michael B. Petras, Jr. will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 7:30 am Eastern.
CLEVELAND, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 7:30 am Eastern. In his presentation, Mr. Petras will provide an update on Sotera Health’s businesses. Sotera Health management, including Chief Financial Officer Scott Leffler, will participate in one-on-one meetings with investors during the conference.
Investors and the general public are invited to listen to the live webcast of Mr. Petras’ presentation by accessing the link on the Sotera Health website under the Investor Relations section: https://investors.soterahealth.com/events-and-presentations. A replay and slides for download will also be made available.
About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
| INVESTOR RELATIONS CONTACTS: | |||
| Sally J. Curley, IRC | Jenny Kobin | ||
| Curley Global IR, LLC | IR Advisory Solutions | ||
| IR@soterahealth.com | IR@soterahealth.com | ||
| MEDIA CONTACT: | |||
| Kristin Gibbs | |||
| Chief Marketing Officer, Sotera Health | |||
| kgibbs@soterahealth.com |
Source: Sotera Health Company
